Exploiting immunogenic cell death to promote antitumor immunity

Authors:

Abstract
No abstract available
Funding Information
  • European Research Council (19-051-ASP)
  • Mark Foundation For Cancer Research (KWF-12539)
  • National Natural Science Foundation of China (2023ZT10Y094)
  • Key Technologies Research and Development Program (2024YFA0918400)
  • National Health Commission of the People's Republic of China
  • Health~Holland (LSH-TKI-LSHM20083)
  • Sun Yat-sen University Cancer Center
  • Ministerie van Volksgezondheid, Welzijn en Sport
  • KWF Kankerbestrijding
  • H2020 European Research Council (ERC-787925)
  • National Key Research and Development Program of China (W2432050)
  • National Key Research and Development Program of China (W2421020)
  • National Key Research and Development Program of China (82372695)
  • National Key Research and Development Program of China (82521103)
  • National Key Research and Development Program of China (82303081)
  • Basic and Applied Basic Research Foundation of Guangdong Province (YTP-SYSUCC-0055)